[86] reported that RG7834, a novel oral HBV gene expression inhibitor, could decrease the amounts of viral proteins and reduce viremia. RG7834 is a small-molecule compound belonging on the dihydroquinolizinones chemical class much like RNAi but via a special system.In addition, this technique could inactivate the mutation of residual viral DNA. The